Not Yet RecruitingPhase 2Phase 3ACTRN12606000024549
Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis
Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis of the knees and/or hips
Sponsor
Healtheries of New Zealand Ltd
Enrollment
100 participants
Start Date
Jan 30, 2006
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 YearssMax Age: 75 Yearss
Inclusion Criteria1
- Total WOMAC score of >30 at baseline-x-ray and clinical evidence of osteoarthritis of the knees and/or hips.
Exclusion Criteria1
- Gout, rheumatoid arthritis or other inflammatory joint condition-Allergy to seafood or gelatine-Use of monoamine oxidase inhibitors-Use of corticosteroids within 4 weeks prior to baseline and throughout the study-Use of aspirin or anti-inflammatory agents 3 weeks prior to baseline and for the duration of the study-Use of complementary anti-arthritic medicines 6 weeks prior to baseline and for the duration of the study-Liver function tests greater then 3 times the upper limit of normal at baseline.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Biolane for a period of 18 weeks
Biolane for a period of 18 weeks
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000024549